カテゴリ： 世界, 医療/バイオ, QYResearch

大腸がん分子診断学の世界市場2023年：ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他

■ 英語タイトル：Global Colorectal Cancer Molecular Diagnostics Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7740）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7740
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：90
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[大腸がん分子診断学の世界市場2023年：ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は大腸がん分子診断学のグローバル市場について調査・分析し、世界の大腸がん分子診断学市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他）、用途別セグメント分析（病院、第三者検査機関、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Roche Diagnostics、Abbott、Thermo Fisher、Qiagen、Illumina、Biomerieux、Bio-Rad、Agilent、Daangene、Amoydxなどが含まれています。大腸がん分子診断学のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、大腸がん分子診断学市場規模を算出する際に考慮しました。

・大腸がん分子診断学市場の概要
- 大腸がん分子診断学の種類別セグメント
- 世界の大腸がん分子診断学市場規模：タイプ別分析（ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他）
- 大腸がん分子診断学の用途別セグメント
- 世界の大腸がん分子診断学市場規模：用途別分析（病院、第三者検査機関、その他）
- 世界の大腸がん分子診断学市場規模予測（2018年-2029年）

・大腸がん分子診断学市場の成長トレンド
- 大腸がん分子診断学の地域別市場規模（2018年-2029年）
- 大腸がん分子診断学市場ダイナミクス
- 大腸がん分子診断学の業界動向
- 大腸がん分子診断学市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他
- 世界の大腸がん分子診断学のタイプ別市場規模（2018年-2023年）
- 世界の大腸がん分子診断学のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、第三者検査機関、その他
- 世界の大腸がん分子診断学の用途別市場規模（2018年-2023年）
- 世界の大腸がん分子診断学の用途別市場規模（2024年-2029年）

・大腸がん分子診断学の地域別市場規模
- 北米の大腸がん分子診断学市場規模（2018年-2029年）
- 米国の大腸がん分子診断学市場規模（2018年-2029年）
- ヨーロッパの大腸がん分子診断学市場規模（2018年-2029年）
- アジア太平洋の大腸がん分子診断学市場規模（2018年-2029年）
- 中国の大腸がん分子診断学市場規模（2018年-2029年）
- 日本の大腸がん分子診断学市場規模（2018年-2029年）
- 韓国の大腸がん分子診断学市場規模（2018年-2029年）
- インドの大腸がん分子診断学市場規模（2018年-2029年）
- オーストラリアの大腸がん分子診断学市場規模（2018年-2029年）
- 中南米の大腸がん分子診断学市場規模（2018年-2029年）
- 中東・アフリカの大腸がん分子診断学市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Roche Diagnostics、Abbott、Thermo Fisher、Qiagen、Illumina、Biomerieux、Bio-Rad、Agilent、Daangene、Amoydx

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Colorectal Cancer Molecular Diagnostics market was valued at US$ 684.5 million in 2022 and is anticipated to reach US$ 1515 million by 2029, witnessing a CAGR of 14.2% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core colorectal cancer molecular diagnostics players include Roche Diagnostics, Abbott and Thermo Fisher etc. The top 3 companies hold a share about 45%. Middle East and Africa is the largest market with a share about 43%, followed by Asia-Pacific and Europe.
In terms of product, polymerase chain reaction PCR is the largest segment with a share about 50%. And in terms of applications, the largest application is third-party testing agency with a share about 48%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Molecular Diagnostics.
The Colorectal Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Colorectal Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx
Segment by Type
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Segment by Application
Hospital
Third-Party Testing Agency
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Polymerase Chain Reaction PCR
1.2.3 Molecular Hybridization
1.2.4 Biochip
1.2.5 Others
1.3 Market by Application
1.3.1 Global Colorectal Cancer Molecular Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Third-Party Testing Agency
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Molecular Diagnostics Market Perspective (2018-2029)
2.2 Colorectal Cancer Molecular Diagnostics Growth Trends by Region
2.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Colorectal Cancer Molecular Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Colorectal Cancer Molecular Diagnostics Market Dynamics
2.3.1 Colorectal Cancer Molecular Diagnostics Industry Trends
2.3.2 Colorectal Cancer Molecular Diagnostics Market Drivers
2.3.3 Colorectal Cancer Molecular Diagnostics Market Challenges
2.3.4 Colorectal Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Colorectal Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Molecular Diagnostics Revenue
3.4 Global Colorectal Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Molecular Diagnostics Revenue in 2022
3.5 Colorectal Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2024-2029)
5 Colorectal Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
6.2 North America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
6.4 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
7.2 Europe Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
7.4 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
9.2 Latin America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Introduction
11.1.4 Roche Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Colorectal Cancer Molecular Diagnostics Introduction
11.2.4 Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Detail
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Introduction
11.3.4 Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.3.5 Thermo Fisher Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Detail
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Introduction
11.4.4 Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.4.5 Qiagen Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Colorectal Cancer Molecular Diagnostics Introduction
11.5.4 Illumina Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.5.5 Illumina Recent Development
11.6 Biomerieux
11.6.1 Biomerieux Company Detail
11.6.2 Biomerieux Business Overview
11.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Introduction
11.6.4 Biomerieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.6.5 Biomerieux Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Detail
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Introduction
11.7.4 Bio-Rad Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.7.5 Bio-Rad Recent Development
11.8 Agilent
11.8.1 Agilent Company Detail
11.8.2 Agilent Business Overview
11.8.3 Agilent Colorectal Cancer Molecular Diagnostics Introduction
11.8.4 Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.8.5 Agilent Recent Development
11.9 Daangene
11.9.1 Daangene Company Detail
11.9.2 Daangene Business Overview
11.9.3 Daangene Colorectal Cancer Molecular Diagnostics Introduction
11.9.4 Daangene Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.9.5 Daangene Recent Development
11.10 Amoydx
11.10.1 Amoydx Company Detail
11.10.2 Amoydx Business Overview
11.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Introduction
11.10.4 Amoydx Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
11.10.5 Amoydx Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Polymerase Chain Reaction PCR
Table 3. Key Players of Molecular Hybridization
Table 4. Key Players of Biochip
Table 5. Key Players of Others
Table 6. Global Colorectal Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Colorectal Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Colorectal Cancer Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Colorectal Cancer Molecular Diagnostics Market Share by Region (2018-2023)
Table 10. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Colorectal Cancer Molecular Diagnostics Market Share by Region (2024-2029)
Table 12. Colorectal Cancer Molecular Diagnostics Market Trends
Table 13. Colorectal Cancer Molecular Diagnostics Market Drivers
Table 14. Colorectal Cancer Molecular Diagnostics Market Challenges
Table 15. Colorectal Cancer Molecular Diagnostics Market Restraints
Table 16. Global Colorectal Cancer Molecular Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Colorectal Cancer Molecular Diagnostics Market Share by Players (2018-2023)
Table 18. Global Top Colorectal Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Molecular Diagnostics as of 2022)
Table 19. Ranking of Global Top Colorectal Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Colorectal Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Colorectal Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Colorectal Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Colorectal Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 27. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2024-2029)
Table 29. Global Colorectal Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Application (2018-2023)
Table 31. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Application (2024-2029)
Table 33. North America Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 48. Roche Diagnostics Company Detail
Table 49. Roche Diagnostics Business Overview
Table 50. Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product
Table 51. Roche Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 52. Roche Diagnostics Recent Development
Table 53. Abbott Company Detail
Table 54. Abbott Business Overview
Table 55. Abbott Colorectal Cancer Molecular Diagnostics Product
Table 56. Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 57. Abbott Recent Development
Table 58. Thermo Fisher Company Detail
Table 59. Thermo Fisher Business Overview
Table 60. Thermo Fisher Colorectal Cancer Molecular Diagnostics Product
Table 61. Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 62. Thermo Fisher Recent Development
Table 63. Qiagen Company Detail
Table 64. Qiagen Business Overview
Table 65. Qiagen Colorectal Cancer Molecular Diagnostics Product
Table 66. Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 67. Qiagen Recent Development
Table 68. Illumina Company Detail
Table 69. Illumina Business Overview
Table 70. Illumina Colorectal Cancer Molecular Diagnostics Product
Table 71. Illumina Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 72. Illumina Recent Development
Table 73. Biomerieux Company Detail
Table 74. Biomerieux Business Overview
Table 75. Biomerieux Colorectal Cancer Molecular Diagnostics Product
Table 76. Biomerieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 77. Biomerieux Recent Development
Table 78. Bio-Rad Company Detail
Table 79. Bio-Rad Business Overview
Table 80. Bio-Rad Colorectal Cancer Molecular Diagnostics Product
Table 81. Bio-Rad Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 82. Bio-Rad Recent Development
Table 83. Agilent Company Detail
Table 84. Agilent Business Overview
Table 85. Agilent Colorectal Cancer Molecular Diagnostics Product
Table 86. Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 87. Agilent Recent Development
Table 88. Daangene Company Detail
Table 89. Daangene Business Overview
Table 90. Daangene Colorectal Cancer Molecular Diagnostics Product
Table 91. Daangene Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 92. Daangene Recent Development
Table 93. Amoydx Company Detail
Table 94. Amoydx Business Overview
Table 95. Amoydx Colorectal Cancer Molecular Diagnostics Product
Table 96. Amoydx Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 97. Amoydx Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Molecular Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Colorectal Cancer Molecular Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. Polymerase Chain Reaction PCR Features
Figure 4. Molecular Hybridization Features
Figure 5. Biochip Features
Figure 6. Others Features
Figure 7. Global Colorectal Cancer Molecular Diagnostics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Colorectal Cancer Molecular Diagnostics Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Third-Party Testing Agency Case Studies
Figure 11. Others Case Studies
Figure 12. Colorectal Cancer Molecular Diagnostics Report Years Considered
Figure 13. Global Colorectal Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Colorectal Cancer Molecular Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Colorectal Cancer Molecular Diagnostics Market Share by Region: 2022 VS 2029
Figure 16. Global Colorectal Cancer Molecular Diagnostics Market Share by Players in 2022
Figure 17. Global Top Colorectal Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Molecular Diagnostics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Colorectal Cancer Molecular Diagnostics Revenue in 2022
Figure 19. North America Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Colorectal Cancer Molecular Diagnostics Market Share by Country (2018-2029)
Figure 21. United States Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Colorectal Cancer Molecular Diagnostics Market Share by Country (2018-2029)
Figure 25. Germany Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Share by Region (2018-2029)
Figure 33. China Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Colorectal Cancer Molecular Diagnostics Market Share by Country (2018-2029)
Figure 41. Mexico Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Share by Country (2018-2029)
Figure 45. Turkey Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Roche Diagnostics Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
Figure 48. Abbott Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
Figure 49. Thermo Fisher Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
Figure 50. Qiagen Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
Figure 51. Illumina Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
Figure 52. Biomerieux Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
Figure 53. Bio-Rad Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
Figure 54. Agilent Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
Figure 55. Daangene Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
Figure 56. Amoydx Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 感染症分子診断のグローバル市場展望 2023年-2029年：ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他
  • がん最小残存病変検査のグローバル市場展望 2023年-2029年：フローサイトメトリー、ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）、その他
  • 最小残存病変（MRD）検査のグローバル市場展望 2023年-2029年：フローサイトメトリー、ポリメラーゼ連鎖反応、次世代シーケンシング、リキッドバイオプシー
  • 水中用レジオネラ菌検査のグローバル市場展望 2023年-2029年：尿抗原検査、ポリメラーゼ連鎖反応、直接蛍光抗体検査、その他
  • 食品安全診断機器のグローバル市場展望 2023年-2029年：クロマトグラフィーシステム、質量分析システム、ポリメラーゼ連鎖反応（PCR）システム、免疫測定システム、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7740 )"大腸がん分子診断学の世界市場2023年：ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他" (英文：Global Colorectal Cancer Molecular Diagnostics Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。